Bruno Labeille is an expert in Dermatology at Centre Hospitalier Universitaire de Saint-Etienne (France). Bruno Labeille has authored 189 publications, the most recent in 2025, and is an investigator in 5 clinical trials. SLR score: 389 (community average: 125). How the SLR is computed.

LeadR Profile

389 ScienceLeadR Reputation 389
Network Map

Dermatology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2025

Source: PubMed

Jean Monnet University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 189

Citations

Citations: 5 184 1st author: 11 Last author: 6 Unique author: 2


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.
PMID 40042819 — safety, skin diseases, rituximab, pemphigus
JAMA Dermatol20250
Author Correction: Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.
PMID 39915680 — cells, molecular biology, enhancer elements, genetic, mutation, carcinoma, basal cell, rna
Nat Med Top journal20250
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
PMID 38265821 — adrenal cortex hormones, follow-up studies, skin diseases, therapeutics, prednisone, safety, enzyme-linked immunosorbent assay, disease-free survival, pemphigus, rituximab
JAMA Dermatol20248
Dermatoscopie de 245 tumeurs selon 4 modalités différentes : étude de l’impact des modalités dermatoscopiques auprès de 3 dermatologues et un logiciel d’intelligence artificielle SkinAI
OpenAlex W4388781686 — data collection, neoplasms, diagnosis, software, dermatologists, dermoscopy
Annales de dermatologie et de vénéréologie, FMC20230
Étude comparative de la mortalité des patients atteints de pemphigus selon l’utilisation du rituximab ou de traitements conventionnels
OpenAlex W3216019098 — rituximab, pemphigus
Annales de dermatologie et de vénéréologie, FMC20210

Clinical Studies 5

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 3 3
N/A 1
Phase 2 1

By status:

Completed 3
Terminated 1
Unknown 1

By type:

Interventional 5

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

LeadR Networks

Main global connection map